These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22142687)

  • 41. A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis.
    Mussen F; Salek S; Walker S
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16 Suppl 1():S2-S15. PubMed ID: 17546573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk assessment of biological hazards in the European Union.
    Hugas M; Tsigarida E; Robinson T; Calistri P
    Int J Food Microbiol; 2007 Nov; 120(1-2):131-5. PubMed ID: 17659800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk-benefit in food safety and nutrition - Outcome of the 2019 Parma Summer School.
    Verhagen H; Alonso-Andicoberry C; Assunção R; Cavaliere F; Eneroth H; Hoekstra J; Koulouris S; Kouroumalis A; Lorenzetti S; Mantovani A; Menozzi D; Nauta M; Poulsen M; Rubert J; Siani A; Sirot V; Spaggiari G; Thomsen ST; Trevisan M; Cozzini P
    Food Res Int; 2021 Mar; 141():110073. PubMed ID: 33641961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical appraisal of the assessment of benefits and risks for foods, 'BRAFO Consensus Working Group'.
    Boobis A; Chiodini A; Hoekstra J; Lagiou P; Przyrembel H; Schlatter J; Schütte K; Verhagen H; Watzl B
    Food Chem Toxicol; 2013 May; 55():659-75. PubMed ID: 23123424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. State of the art in benefit-risk analysis: medicines.
    Luteijn JM; White BC; Gunnlaugsdóttir H; Holm F; Kalogeras N; Leino O; Magnússon SH; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; McCarron PA; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):26-32. PubMed ID: 21683115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An appeal for the presentation of detailed human derived data for dose-response calculations in nutritional science.
    de Jong N; Verkaik-Kloosterman J; Verhagen H; Boshuizen HC; Bokkers B; Hoekstra J
    Food Chem Toxicol; 2013 Apr; 54():43-9. PubMed ID: 22902968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of strategies for effective communication of food risks and benefits across Europe: design and conceptual framework of the FoodRisC project.
    Barnett J; McConnon A; Kennedy J; Raats M; Shepherd R; Verbeke W; Fletcher J; Kuttschreuter M; Lima L; Wills J; Wall P
    BMC Public Health; 2011 May; 11():308. PubMed ID: 21569458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety impact--the risk/benefits of functional foods.
    Pascal G
    Eur J Nutr; 2009 Dec; 48 Suppl 1():S33-9. PubMed ID: 19937442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Consumer responses to integrated risk-benefit information associated with the consumption of food.
    van Dijk H; Fischer AR; Frewer LJ
    Risk Anal; 2011 Mar; 31(3):429-39. PubMed ID: 20880220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Translating reference doses into allergen management practice: challenges for stakeholders.
    Crevel RW; Baumert JL; Luccioli S; Baka A; Hattersley S; Hourihane JO; Ronsmans S; Timmermans F; Ward R; Chung YJ
    Food Chem Toxicol; 2014 May; 67():277-87. PubMed ID: 24491260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
    Brass EP; Lofstedt R; Renn O
    J Clin Pharmacol; 2013 May; 53(5):475-82. PubMed ID: 23381796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk/Benefit Communication about Food-A Systematic Review of the Literature.
    Frewer LJ; Fischer AR; Brennan M; Bánáti D; Lion R; Meertens RM; Rowe G; Siegrist M; Verbeke W; Vereijken CM
    Crit Rev Food Sci Nutr; 2016 Jul; 56(10):1728-45. PubMed ID: 25575335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products".
    Smith MY; Hammad TA; Metcalf M; Levitan B; Noel R; Wolka AM; Michaels DL; Johnson FR
    Ther Innov Regul Sci; 2016 Sep; 50(5):546-553. PubMed ID: 30231755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optofluidic opportunities in global health, food, water and energy.
    Chen YF; Jiang L; Mancuso M; Jain A; Oncescu V; Erickson D
    Nanoscale; 2012 Aug; 4(16):4839-57. PubMed ID: 22763418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of Structured Benefit-Risk Assessments in Marketing Authorization Applications: Lessons Learned.
    Wang J; Wolka A; Bullok K; Anglin G; Radawski C; Noel R
    Ther Innov Regul Sci; 2016 Nov; 50(6):718-723. PubMed ID: 30231743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Communicating Food Risk-Benefit Assessments: Edible Insects as Red Meat Replacers.
    Boehm E; Borzekowski D; Ververis E; Lohmann M; Böl GF
    Front Nutr; 2021; 8():749696. PubMed ID: 34977112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A practical approach to communicating benefit-risk decisions of medicines to stakeholders.
    Leong J; Walker S; Salek S
    Front Pharmacol; 2015; 6():99. PubMed ID: 26124720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The unaccountable risks of LIBOR.
    Bryan D; Rafferty M
    Br J Sociol; 2016 Mar; 67(1):71-96. PubMed ID: 26876305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Need for a Paradigm Shift in Healthy Nutrition Research.
    Aleta A; Brighenti F; Jolliet O; Meijaard E; Shamir R; Moreno Y; Rasetti M
    Front Nutr; 2022; 9():881465. PubMed ID: 35520286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.